Sanofi-Aventis S.A. ADR (SNY)

Apr 3, 2025, 1:00 AM EDT - 4 hours ago

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Apr 1, 2025, 12:11 PM EDT - 1 day ago

Bernstein's Courtney Breen: Merck, Novo Nordisk, others at high risk from tariffs

MRK NVO ABBV GSK

Mar 28, 2025, 4:07 PM EDT - 5 days ago

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Mar 28, 2025, 2:27 PM EDT - 5 days ago

US FDA approves Sanofi's bleeding disorder therapy

Mar 28, 2025, 9:44 AM EDT - 5 days ago

AbbVie Vs. Sanofi: Which Is The Better Investment Right Now

ABBV

Mar 28, 2025, 2:00 AM EDT - 6 days ago

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

REGN

Mar 26, 2025, 2:00 AM EDT - 8 days ago

Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

Mar 25, 2025, 2:00 AM EDT - 9 days ago

Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

Mar 24, 2025, 2:30 AM EDT - 10 days ago

Press Release: Availability of the Q1 2025 Aide mémoire

Mar 20, 2025, 2:29 AM EDT - 14 days ago

Sanofi to acquire Dren Bio's immunology unit

Mar 20, 2025, 2:00 AM EDT - 14 days ago

Press Release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Mar 14, 2025, 2:18 PM EDT - 19 days ago

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

Mar 12, 2025, 10:12 AM EDT - 21 days ago

Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?

Mar 11, 2025, 8:55 AM EDT - 22 days ago

Top 3 Health Care Stocks That May Keep You Up At Night In Q1

TSVT VRTX

Mar 8, 2025, 1:00 PM EST - 25 days ago

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

REGN

Mar 5, 2025, 12:10 PM EST - 4 weeks ago

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

Mar 4, 2025, 12:14 PM EST - 4 weeks ago

South African watchdog probes Novo Nordisk and Sanofi over insulin

NVO

Feb 26, 2025, 10:14 AM EST - 5 weeks ago

Health Rounds: Experimental Sanofi drug delays heart valve disease progression, and potentially surgery

Feb 26, 2025, 9:00 AM EST - 5 weeks ago

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

Feb 25, 2025, 1:00 AM EST - 5 weeks ago

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

Feb 22, 2025, 2:30 AM EST - 5 weeks ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease

Feb 19, 2025, 7:19 AM EST - 6 weeks ago

Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth

Feb 19, 2025, 1:30 AM EST - 6 weeks ago

Press Release: Sanofi and CD&R sign Opella share purchase agreement

Feb 13, 2025, 2:09 PM EST - 6 weeks ago

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report

Feb 13, 2025, 1:00 AM EST - 7 weeks ago

Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

Feb 7, 2025, 1:13 AM EST - 7 weeks ago

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Feb 7, 2025, 1:00 AM EST - 7 weeks ago

Press Release: Execution of a share buyback agreement for up to €2 billion

Feb 4, 2025, 5:30 AM EST - 2 months ago

MITEM PHARMA Continues Its Mission to Protect the Interests of Patients Suffering From Rare and Lethal Diseases by Acquiring the FLISINT® Speciality from SANOFI

Feb 3, 2025, 1:30 AM EST - 2 months ago

Agreement Between L'Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L'Oréal

Feb 3, 2025, 1:30 AM EST - 2 months ago

Press Release: Sanofi announces buy back of shares from L'Oréal

Jan 31, 2025, 1:00 AM EST - 2 months ago

Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

Jan 30, 2025, 2:41 PM EST - 2 months ago

Sanofi (SNY) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 10:30 AM EST - 2 months ago

Sanofi CEO Paul Hudson on RFK Jr.'s vaccine stance

Jan 30, 2025, 7:15 AM EST - 2 months ago

Sanofi CEO Paul Hudson on Q4 results: We've set ourselves up very well for 2025

Jan 30, 2025, 1:33 AM EST - 2 months ago

Sanofi meets estimates for fourth-quarter profit, plans 5 billion euros in buybacks

Jan 23, 2025, 1:00 PM EST - 2 months ago

'The next battleground': Sanofi exploring opportunities in second generation obesity drugs

Jan 22, 2025, 1:00 AM EST - 2 months ago

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Jan 21, 2025, 1:00 AM EST - 2 months ago

Press Release: Opella reaches study milestone for Cialis

Jan 19, 2025, 4:54 PM EST - 2 months ago

Top 4 Immunology Stocks Poised For Growth In 2025

ABBV BMY TEVA

Jan 14, 2025, 3:30 PM EST - 2 months ago

Sanofi (SYN) CEO Paul Hudson Hosts 43rd Annual J.P. Morgan Healthcare (Transcript)

Jan 13, 2025, 6:10 PM EST - 2 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Jan 13, 2025, 9:00 AM EST - 2 months ago

Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi

Jan 13, 2025, 1:00 AM EST - 2 months ago

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

Jan 10, 2025, 11:45 AM EST - 2 months ago

Sanofi: Underappreciated Powerhouse Primed For Long-Term Growth (Rating Upgrade)

Jan 9, 2025, 1:00 AM EST - 3 months ago

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Jan 7, 2025, 10:00 AM EST - 3 months ago

Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with Sanofi

Jan 2, 2025, 5:51 AM EST - 3 months ago

Gaming stocks likely to outperform semiconductor stocks in 2025

EA MSFT TTWO

Dec 31, 2024, 7:05 AM EST - 3 months ago

Drugmakers to raise US prices on over 250 medicines starting Jan. 1

BMY PFE

Dec 23, 2024, 1:00 AM EST - 3 months ago

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Dec 19, 2024, 12:00 PM EST - 3 months ago

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors